{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:23:09Z","timestamp":1790202189287,"version":"4.1.0"},"reference-count":140,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N02379X\/1"],"award-info":[{"award-number":["MR\/N02379X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00258","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:01:04Z","timestamp":1489449664000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":57,"title":["Type I and III Interferon in the Gut: Tight Balance between Host Protection and Immunopathology"],"prefix":"10.3389","volume":"8","author":[{"given":"Johanna","family":"Pott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Stockinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"issue":"8","key":"B1","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/embor.2012.96","article-title":"Innate immune signalling at the intestinal epithelium in homeostasis and disease","volume":"13","author":"Pott","year":"2012","journal-title":"EMBO Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/bs.ai.2014.11.003","article-title":"Epithelial cell contributions to intestinal immunity","volume":"126","author":"Hooper","year":"2015","journal-title":"Adv Immunol"},{"issue":"9","key":"B3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nri1684","article-title":"The yin and yang of type I interferon activity in bacterial infection","volume":"5","author":"Decker","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"9\u201310","key":"B4","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.imbio.2008.07.020","article-title":"Novel functions of type I interferons revealed by infection studies with Listeria monocytogenes","volume":"213","author":"Stockinger","year":"2008","journal-title":"Immunobiology"},{"issue":"2","key":"B5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"B6","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.4049\/jimmunol.1402794","article-title":"Interfering with immunity: detrimental role of type I IFNs during infection","volume":"194","author":"Stifter","year":"2015","journal-title":"J Immunol"},{"issue":"1","key":"B7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"issue":"1","key":"B8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat Immunol"},{"issue":"8","key":"B9","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ni.3212","article-title":"Guarding the frontiers: the biology of type III interferons","volume":"16","author":"Wack","year":"2015","journal-title":"Nat Immunol"},{"issue":"9","key":"B10","doi-asserted-by":"publisher","first-page":"e1000151","DOI":"10.1371\/journal.ppat.1000151","article-title":"Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses","volume":"4","author":"Mordstein","year":"2008","journal-title":"PLoS Pathog"},{"issue":"11","key":"B11","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1128\/JVI.00272-10","article-title":"Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections","volume":"84","author":"Mordstein","year":"2010","journal-title":"J Virol"},{"issue":"19","key":"B12","doi-asserted-by":"publisher","first-page":"7944","DOI":"10.1073\/pnas.1100552108","article-title":"IFN-lambda determines the intestinal epithelial antiviral host defense","volume":"108","author":"Pott","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6219","key":"B13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1126\/science.1258025","article-title":"Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection","volume":"347","author":"Baldridge","year":"2015","journal-title":"Science"},{"issue":"4","key":"B14","doi-asserted-by":"publisher","first-page":"e1004782","DOI":"10.1371\/journal.ppat.1004782","article-title":"Leukocyte-derived IFN-alpha\/beta and epithelial IFN-lambda constitute a compartmentalized mucosal defense system that restricts enteric virus infections","volume":"11","author":"Mahlakoiv","year":"2015","journal-title":"PLoS Pathog"},{"issue":"6219","key":"B15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1258100","article-title":"Interferon-lambda cures persistent murine norovirus infection in the absence of adaptive immunity","volume":"347","author":"Nice","year":"2015","journal-title":"Science"},{"issue":"1","key":"B16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2015.07.001","article-title":"Interferon-lambda: immune functions at barrier surfaces and beyond","volume":"43","author":"Lazear","year":"2015","journal-title":"Immunity"},{"issue":"8","key":"B17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ni.2915","article-title":"Diverse intracellular pathogens activate type III interferon expression from peroxisomes","volume":"15","author":"Odendall","year":"2014","journal-title":"Nat Immunol"},{"issue":"8","key":"B18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1089\/jir.2010.0063","article-title":"Mechanisms of type III interferon expression","volume":"30","author":"Iversen","year":"2010","journal-title":"J Interferon Cytokine Res"},{"issue":"10","key":"B19","doi-asserted-by":"publisher","first-page":"7576","DOI":"10.1074\/jbc.M608618200","article-title":"Viral infections activate types I and III interferon genes through a common mechanism","volume":"282","author":"Onoguchi","year":"2007","journal-title":"J Biol Chem"},{"issue":"6","key":"B20","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.4049\/jimmunol.179.6.3434","article-title":"IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes","volume":"179","author":"Osterlund","year":"2007","journal-title":"J Immunol"},{"issue":"28","key":"B21","doi-asserted-by":"publisher","first-page":"11564","DOI":"10.1073\/pnas.0904477106","article-title":"The role of transposable elements in the regulation of IFN-lambda1 gene expression","volume":"106","author":"Thomson","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"B22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1128\/JVI.79.1.17-27.2005","article-title":"Plasmacytoid dendritic cells: linking innate and adaptive immunity","volume":"79","author":"McKenna","year":"2005","journal-title":"J Virol"},{"issue":"5","key":"B23","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.4049\/jimmunol.1301093","article-title":"Type I IFNs regulate effector and regulatory T cell accumulation and anti-inflammatory cytokine production during T cell-mediated colitis","volume":"191","author":"Kole","year":"2013","journal-title":"J Immunol"},{"issue":"8","key":"B24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"Swiecki","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"B25","doi-asserted-by":"publisher","first-page":"e1000355","DOI":"10.1371\/journal.ppat.1000355","article-title":"Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes","volume":"5","author":"Stockinger","year":"2009","journal-title":"PLoS Pathog"},{"issue":"12","key":"B26","doi-asserted-by":"publisher","first-page":"e15567","DOI":"10.1371\/journal.pone.0015567","article-title":"A fluorescence reporter model defines \u201cTip-DCs\u201d as the cellular source of interferon beta in murine listeriosis","volume":"5","author":"Dresing","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"B27","doi-asserted-by":"publisher","first-page":"e18543","DOI":"10.1371\/journal.pone.0018543","article-title":"Production of IFN-beta during Listeria monocytogenes infection is restricted to monocyte\/macrophage lineage","volume":"6","author":"Solodova","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"B28","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1002\/eji.200425882","article-title":"Immunomodulatory dendritic cells in intestinal lamina propria","volume":"35","author":"Chirdo","year":"2005","journal-title":"Eur J Immunol"},{"issue":"7","key":"B29","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ni.3180","article-title":"Interferon-lambda and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection","volume":"16","author":"Hernandez","year":"2015","journal-title":"Nat Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7090","DOI":"10.1038\/ncomms8090","article-title":"Intestinal intraepithelial lymphocyte activation promotes innate antiviral resistance","volume":"6","author":"Swamy","year":"2015","journal-title":"Nat Commun"},{"issue":"204","key":"B31","doi-asserted-by":"publisher","first-page":"204ra129","DOI":"10.1126\/scitranslmed.3006245","article-title":"IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis","volume":"5","author":"Wolk","year":"2013","journal-title":"Sci Transl Med"},{"issue":"7","key":"B32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/j.1462-5822.2010.01478.x","article-title":"Induction of type I interferons by bacteria","volume":"12","author":"Monroe","year":"2010","journal-title":"Cell Microbiol"},{"issue":"6","key":"B33","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.chom.2016.05.016","article-title":"The roles of type I interferon in bacterial infection","volume":"19","author":"Boxx","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"6022","key":"B34","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1126\/science.1200120","article-title":"A bacterial protein targets the BAHD1 chromatin complex to stimulate type III interferon response","volume":"331","author":"Lebreton","year":"2011","journal-title":"Science"},{"issue":"6","key":"B35","doi-asserted-by":"publisher","first-page":"e39080","DOI":"10.1371\/journal.pone.0039080","article-title":"Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta","volume":"7","author":"Bierne","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"B36","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1189\/jlb.1009651","article-title":"Inhibition of dynamin-dependent endocytosis interferes with type III IFN expression in bacteria-infected human monocyte-derived DCs","volume":"88","author":"Pietila","year":"2010","journal-title":"J Leukoc Biol"},{"issue":"4","key":"B37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.molimm.2010.10.005","article-title":"TLR ligands induce synergistic interferon-beta and interferon-lambda1 gene expression in human monocyte-derived dendritic cells","volume":"48","author":"Makela","year":"2011","journal-title":"Mol Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"B39","doi-asserted-by":"publisher","first-page":"e1000017","DOI":"10.1371\/journal.ppat.1000017","article-title":"IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo","volume":"4","author":"Sommereyns","year":"2008","journal-title":"PLoS Pathog"},{"issue":"17","key":"B40","doi-asserted-by":"publisher","first-page":"8626","DOI":"10.1128\/JVI.00303-10","article-title":"Temporal and spatial resolution of type I and III interferon responses in vivo","volume":"84","author":"Pulverer","year":"2010","journal-title":"J Virol"},{"issue":"18","key":"B41","doi-asserted-by":"publisher","first-page":"E2376","DOI":"10.1073\/pnas.1424241112","article-title":"NK cells require IL-28R for optimal in vivo activity","volume":"112","author":"Souza-Fonseca-Guimaraes","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"B42","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1084\/jem.20140995","article-title":"IFN-lambda resolves inflammation via suppression of neutrophil infiltration and IL-1beta production","volume":"212","author":"Blazek","year":"2015","journal-title":"J Exp Med"},{"issue":"4","key":"B43","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1189\/jlb.3A0215-041RR","article-title":"IFN-lambda is able to augment TLR-mediated activation and subsequent function of primary human B cells","volume":"98","author":"de Groen","year":"2015","journal-title":"J Leukoc Biol"},{"issue":"10","key":"B44","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/JCI15770","article-title":"IFNs and STATs in innate immunity to microorganisms","volume":"109","author":"Decker","year":"2002","journal-title":"J Clin Invest"},{"issue":"5167","key":"B45","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"issue":"Pt 6","key":"B46","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1099\/vir.0.80904-0","article-title":"Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model","volume":"86","author":"Bartlett","year":"2005","journal-title":"J Gen Virol"},{"issue":"9","key":"B47","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1128\/JVI.80.9.4501-4509.2006","article-title":"Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo","volume":"80","author":"Ank","year":"2006","journal-title":"J Virol"},{"issue":"6","key":"B48","doi-asserted-by":"publisher","first-page":"e1005684","DOI":"10.1371\/journal.ppat.1005684","article-title":"Type I interferon receptor deficiency in dendritic cells facilitates systemic murine norovirus persistence despite enhanced adaptive immunity","volume":"12","author":"Nice","year":"2016","journal-title":"PLoS Pathog"},{"issue":"15","key":"B49","doi-asserted-by":"publisher","first-page":"7578","DOI":"10.1128\/JVI.00391-08","article-title":"Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice","volume":"82","author":"Feng","year":"2008","journal-title":"J Virol"},{"issue":"4","key":"B50","doi-asserted-by":"publisher","first-page":"e1005600","DOI":"10.1371\/journal.ppat.1005600","article-title":"Distinct roles of type I and type III interferons in intestinal immunity to homologous and heterologous rotavirus infections","volume":"12","author":"Lin","year":"2016","journal-title":"PLoS Pathog"},{"issue":"5612","key":"B51","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1126\/science.1077905","article-title":"STAT1-dependent innate immunity to a Norwalk-like virus","volume":"299","author":"Karst","year":"2003","journal-title":"Science"},{"issue":"6262","key":"B52","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.aab3145","article-title":"Nlrp6 regulates intestinal antiviral innate immunity","volume":"350","author":"Wang","year":"2015","journal-title":"Science"},{"issue":"6","key":"B53","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1089\/107999099313802","article-title":"Lack of a role for type I and type II interferons in the resolution of rotavirus-induced diarrhea and infection in mice","volume":"19","author":"Angel","year":"1999","journal-title":"J Interferon Cytokine Res"},{"issue":"6","key":"B54","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.chom.2014.05.015","article-title":"Advances in norovirus biology","volume":"15","author":"Karst","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"12","key":"B55","doi-asserted-by":"publisher","first-page":"e432","DOI":"10.1371\/journal.pbio.0020432","article-title":"Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages","volume":"2","author":"Wobus","year":"2004","journal-title":"PLoS Biol"},{"issue":"12","key":"B56","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1128\/JVI.00204-14","article-title":"Efficient norovirus and reovirus replication in the mouse intestine requires microfold (M) cells","volume":"88","author":"Gonzalez-Hernandez","year":"2014","journal-title":"J Virol"},{"issue":"11","key":"B57","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1128\/JVI.00231-09","article-title":"Type I and type II interferons inhibit the translation of murine norovirus proteins","volume":"83","author":"Changotra","year":"2009","journal-title":"J Virol"},{"issue":"4","key":"B58","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.chom.2012.03.002","article-title":"Nondegradative role of Atg5-Atg12\/Atg16L1 autophagy protein complex in antiviral activity of interferon gamma","volume":"11","author":"Hwang","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"24","key":"B59","doi-asserted-by":"publisher","first-page":"13515","DOI":"10.1128\/JVI.01824-12","article-title":"Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication","volume":"86","author":"Thackray","year":"2012","journal-title":"J Virol"},{"issue":"6","key":"B60","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1084\/jem.20061587","article-title":"Type I interferons produced by hematopoietic cells protect mice against lethal infection by mammalian reovirus","volume":"204","author":"Johansson","year":"2007","journal-title":"J Exp Med"},{"issue":"12","key":"B61","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/intimm\/dxt050","article-title":"Confounding roles for type I interferons during bacterial and viral pathogenesis","volume":"25","author":"Carrero","year":"2013","journal-title":"Int Immunol"},{"issue":"4","key":"B62","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1084\/jem.20040976","article-title":"Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes","volume":"200","author":"Auerbuch","year":"2004","journal-title":"J Exp Med"},{"issue":"8","key":"B63","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.4049\/jimmunol.172.8.4866","article-title":"Listeriolysin O from Listeria monocytogenes is a lymphocyte apoptogenic molecule","volume":"172","author":"Carrero","year":"2004","journal-title":"J Immunol"},{"issue":"4","key":"B64","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1084\/jem.20040712","article-title":"Type I interferon production enhances susceptibility to Listeria monocytogenes infection","volume":"200","author":"O\u2019Connell","year":"2004","journal-title":"J Exp Med"},{"issue":"6","key":"B65","doi-asserted-by":"publisher","first-page":"e65007","DOI":"10.1371\/journal.pone.0065007","article-title":"Route of infection determines the impact of type I interferons on innate immunity to Listeria monocytogenes","volume":"8","author":"Kernbauer","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"B66","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.4049\/jimmunol.1502192","article-title":"Type I IFN does not promote susceptibility to foodborne Listeria monocytogenes","volume":"196","author":"Pitts","year":"2016","journal-title":"J Immunol"},{"issue":"5","key":"B67","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.4049\/jimmunol.1500105","article-title":"Salmonella Typhimurium co-opts the host type I IFN system to restrict macrophage innate immune transcriptional responses selectively","volume":"195","author":"Perkins","year":"2015","journal-title":"J Immunol"},{"issue":"5","key":"B68","doi-asserted-by":"publisher","first-page":"e1005572","DOI":"10.1371\/journal.ppat.1005572","article-title":"Influenza virus affects intestinal microbiota and secondary Salmonella infection in the gut through type I interferons","volume":"12","author":"Deriu","year":"2016","journal-title":"PLoS Pathog"},{"issue":"7","key":"B69","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/gene.2011.38","article-title":"Impact of Usp18 and IFN signaling in Salmonella-induced typhlitis","volume":"12","author":"Richer","year":"2011","journal-title":"Genes Immun"},{"issue":"13","key":"B70","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1084\/jem.20110547","article-title":"Host innate recognition of an intestinal bacterial pathogen induces TRIF-dependent protective immunity","volume":"208","author":"Sotolongo","year":"2011","journal-title":"J Exp Med"},{"issue":"1","key":"B71","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.gastro.2012.03.042","article-title":"Type I interferons maintain Foxp3 expression and T-regulatory cell functions under inflammatory conditions in mice","volume":"143","author":"Lee","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"B72","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.4049\/jimmunol.1100765","article-title":"CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential","volume":"188","author":"Radulovic","year":"2012","journal-title":"J Immunol"},{"issue":"3","key":"B73","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1172\/JCI22996","article-title":"Toll-like receptor 9-induced type I IFN protects mice from experimental colitis","volume":"115","author":"Katakura","year":"2005","journal-title":"J Clin Invest"},{"issue":"2","key":"B74","doi-asserted-by":"publisher","first-page":"e16967","DOI":"10.1371\/journal.pone.0016967","article-title":"Localized delivery of interferon-beta by Lactobacillus exacerbates experimental colitis","volume":"6","author":"McFarland","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"B75","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1002\/eji.201344401","article-title":"Type I interferons have opposing effects during the emergence and recovery phases of colitis","volume":"44","author":"Rauch","year":"2014","journal-title":"Eur J Immunol"},{"issue":"12","key":"B76","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1136\/gutjnl-2013-305863","article-title":"Type I interferon signalling in the intestinal epithelium affects Paneth cells, microbial ecology and epithelial regeneration","volume":"63","author":"Tschurtschenthaler","year":"2014","journal-title":"Gut"},{"issue":"13","key":"B77","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1128\/MCB.01498-14","article-title":"Noncanonical effects of IRF9 in intestinal inflammation: more than type I and type III interferons","volume":"35","author":"Rauch","year":"2015","journal-title":"Mol Cell Biol"},{"issue":"4","key":"B78","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20040769","article-title":"Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection","volume":"200","author":"Carrero","year":"2004","journal-title":"J Exp Med"},{"issue":"4","key":"B79","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1128\/IAI.01251-07","article-title":"Stimulation of inducible nitric oxide synthase expression by beta interferon increases necrotic death of macrophages upon Listeria monocytogenes infection","volume":"76","author":"Zwaferink","year":"2008","journal-title":"Infect Immun"},{"issue":"4","key":"B80","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1084\/jem.20060045","article-title":"Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes","volume":"203","author":"Carrero","year":"2006","journal-title":"J Exp Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/gutjnl-2015-311224","article-title":"Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis","volume":"66","author":"Hackstein","year":"2016","journal-title":"Gut"},{"issue":"2","key":"B82","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1084\/jem.20091746","article-title":"Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma","volume":"207","author":"Rayamajhi","year":"2010","journal-title":"J Exp Med"},{"issue":"49","key":"B83","doi-asserted-by":"publisher","first-page":"19484","DOI":"10.1073\/pnas.1112371108","article-title":"Illuminating the landscape of host-pathogen interactions with the bacterium Listeria monocytogenes","volume":"108","author":"Cossart","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7216","key":"B84","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nature07303","article-title":"Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis","volume":"455","author":"Disson","year":"2008","journal-title":"Nature"},{"issue":"41","key":"B85","doi-asserted-by":"publisher","first-page":"16684","DOI":"10.1073\/pnas.1212809109","article-title":"Impact of lactobacilli on orally acquired listeriosis","volume":"109","author":"Archambaud","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B86","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-3-642-01846-6_4","article-title":"Molecular mechanisms of Salmonella virulence and host resistance","volume":"337","author":"Valdez","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"issue":"5","key":"B87","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1128\/IAI.71.5.2839-2858.2003","article-title":"Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host","volume":"71","author":"Barthel","year":"2003","journal-title":"Infect Immun"},{"issue":"9","key":"B88","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1128\/IAI.00072-06","article-title":"Chronic Salmonella enterica serovar Typhimurium-induced colitis and cholangitis in streptomycin-pretreated Nramp1+\/+ mice","volume":"74","author":"Stecher","year":"2006","journal-title":"Infect Immun"},{"issue":"6","key":"B89","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.4049\/jimmunol.1000890","article-title":"N-ethyl-N-nitrosourea-induced mutation in ubiquitin-specific peptidase 18 causes hyperactivation of IFN-alphass signaling and suppresses STAT4-induced IFN-gamma production, resulting in increased susceptibility to Salmonella typhimurium","volume":"185","author":"Richer","year":"2010","journal-title":"J Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"18232","DOI":"10.1074\/jbc.M116.738278","article-title":"Citrobacter rodentium NleB inhibits tumor necrosis factor (TNF) receptor-associated factor 3 (TRAF3) ubiquitination to reduce host type I interferon production","volume":"291","author":"Gao","year":"2016","journal-title":"J Biol Chem"},{"issue":"7","key":"B91","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1128\/IAI.00105-14","article-title":"Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function","volume":"82","author":"Long","year":"2014","journal-title":"Infect Immun"},{"issue":"3","key":"B92","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cell.2012.07.007","article-title":"TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria","volume":"150","author":"Rathinam","year":"2012","journal-title":"Cell"},{"issue":"3","key":"B93","doi-asserted-by":"publisher","first-page":"e34416","DOI":"10.1371\/journal.pone.0034416","article-title":"Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice","volume":"7","author":"Huizinga","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"B94","doi-asserted-by":"publisher","first-page":"e20953","DOI":"10.1371\/journal.pone.0020953","article-title":"Novel murine infection models provide deep insights into the \u201cmenage a trois\u201d of Campylobacter jejuni, microbiota and host innate immunity","volume":"6","author":"Bereswill","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"B95","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ana.24442","article-title":"Innate immunity to Campylobacter jejuni in Guillain\u2013Barre syndrome","volume":"78","author":"Huizinga","year":"2015","journal-title":"Ann Neurol"},{"issue":"11","key":"B96","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.it.2014.07.010","article-title":"Modulation of immune development and function by intestinal microbiota","volume":"35","author":"Kabat","year":"2014","journal-title":"Trends Immunol"},{"issue":"8","key":"B97","doi-asserted-by":"publisher","first-page":"e72317","DOI":"10.1371\/journal.pone.0072317","article-title":"Differences in mucosal gene expression in the colon of two inbred mouse strains after colonization with commensal gut bacteria","volume":"8","author":"Brodziak","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"B98","doi-asserted-by":"publisher","first-page":"e10335","DOI":"10.1371\/journal.pone.0010335","article-title":"Community dynamics in the mouse gut microbiota: a possible role for IRF9-regulated genes in community homeostasis","volume":"5","author":"Thompson","year":"2010","journal-title":"PLoS One"},{"key":"B99","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cytogfr.2016.03.002","article-title":"The emerging role of interferon regulatory factor 9 in the antiviral host response and beyond","volume":"29","author":"Suprunenko","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"issue":"12","key":"B100","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1371\/journal.pbio.0040413","article-title":"Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host","volume":"4","author":"Sonnenburg","year":"2006","journal-title":"PLoS Biol"},{"issue":"1","key":"B101","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.immuni.2012.04.011","article-title":"Commensal bacteria calibrate the activation threshold of innate antiviral immunity","volume":"37","author":"Abt","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"B102","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.immuni.2012.05.020","article-title":"Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota","volume":"37","author":"Ganal","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"B103","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.immuni.2012.07.001","article-title":"Maintaining poise: commensal microbiota calibrate interferon responses","volume":"37","author":"McAleer","year":"2012","journal-title":"Immunity"},{"issue":"5","key":"B104","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.4049\/jimmunol.179.5.2690","article-title":"Cutting edge: Peyer\u2019s patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype","volume":"179","author":"Contractor","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"B105","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.immuni.2011.02.002","article-title":"Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction","volume":"34","author":"Tezuka","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"B106","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.chom.2014.11.004","article-title":"Type I interferons link viral infection to enhanced epithelial turnover and repair","volume":"17","author":"Sun","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"7","key":"B107","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1128\/MCB.00988-15","article-title":"Type I interferons control proliferation and function of the intestinal epithelium","volume":"36","author":"Katlinskaya","year":"2016","journal-title":"Mol Cell Biol"},{"issue":"24","key":"B108","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1128\/MCB.00478-09","article-title":"Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling","volume":"29","author":"Liu","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"11","key":"B109","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/intimm\/5.11.1461","article-title":"Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice","volume":"5","author":"Powrie","year":"1993","journal-title":"Int Immunol"},{"issue":"8","key":"B110","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.4049\/jimmunol.170.8.3939","article-title":"Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells","volume":"170","author":"Mottet","year":"2003","journal-title":"J Immunol"},{"issue":"1","key":"B111","doi-asserted-by":"publisher","first-page":"e23820","DOI":"10.4161\/jkst.23820","article-title":"The regulation of inflammation by interferons and their STATs","volume":"2","author":"Rauch","year":"2013","journal-title":"JAKSTAT"},{"issue":"10","key":"B112","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1136\/gut.2009.193177","article-title":"T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells","volume":"59","author":"Hofmann","year":"2010","journal-title":"Gut"},{"issue":"7083","key":"B113","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature04606","article-title":"CD69 acts downstream of interferon-alpha\/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs","volume":"440","author":"Shiow","year":"2006","journal-title":"Nature"},{"key":"B114","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/1471-2164-9-192","article-title":"Importance of the interferon-alpha system in murine large intestine indicated by microarray analysis of commensal bacteria-induced immunological changes","volume":"9","author":"Munakata","year":"2008","journal-title":"BMC Genomics"},{"key":"B115","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-physiol-030212-183744","article-title":"Paneth cells: maestros of the small intestinal crypts","volume":"75","author":"Clevers","year":"2013","journal-title":"Annu Rev Physiol"},{"issue":"5","key":"B116","doi-asserted-by":"publisher","first-page":"G960","DOI":"10.1152\/ajpgi.00126.2005","article-title":"IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression","volume":"289","author":"Brand","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7351","key":"B117","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10208","article-title":"Intestinal homeostasis and its breakdown in inflammatory bowel disease","volume":"474","author":"Maloy","year":"2011","journal-title":"Nature"},{"issue":"7422","key":"B118","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"issue":"7351","key":"B119","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"key":"B120","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/mi.2016.44","article-title":"Regulation of human intestinal T-cell responses by type 1 interferon-STAT1 signaling is disrupted in inflammatory bowel disease","volume":"10","author":"Giles","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"4","key":"B121","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nm.2110","article-title":"T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis","volume":"16","author":"Axtell","year":"2010","journal-title":"Nat Med"},{"issue":"4","key":"B122","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/BF02064982","article-title":"Prospective evaluation of interferon-alpha in treatment of chronic active Crohn\u2019s disease","volume":"40","author":"Gasche","year":"1995","journal-title":"Dig Dis Sci"},{"issue":"6","key":"B123","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1111\/j.1572-0241.2001.03875.x","article-title":"An open-labeled, randomized study comparing systemic interferon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis","volume":"96","author":"Madsen","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"B124","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1136\/gut.52.9.1286","article-title":"Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study","volume":"52","author":"Nikolaus","year":"2003","journal-title":"Gut"},{"issue":"12","key":"B125","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1136\/gut.52.12.1728","article-title":"A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis","volume":"52","author":"Tilg","year":"2003","journal-title":"Gut"},{"issue":"6","key":"B126","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1365-2036.2008.03778.x","article-title":"Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-beta-la in moderately active ulcerative colitis","volume":"28","author":"Pena-Rossi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"B127","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-230X-9-22","article-title":"Interferon beta-1a for the maintenance of remission in patients with Crohn\u2019s disease: results of a phase II dose-finding study","volume":"9","author":"Pena-Rossi","year":"2009","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"B128","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/gut.2010.226860","article-title":"Suppression of inflammation in ulcerative colitis by interferon-beta-1a is accompanied by inhibition of IL-13 production","volume":"60","author":"Mannon","year":"2011","journal-title":"Gut"},{"issue":"9","key":"B129","doi-asserted-by":"publisher","first-page":"CD006790","DOI":"10.1002\/14651858.CD006790.pub3","article-title":"Type I interferons for induction of remission in ulcerative colitis","author":"Wang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"B130","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2012.06.006","article-title":"Celiac disease: an immunological jigsaw","volume":"36","author":"Meresse","year":"2012","journal-title":"Immunity"},{"issue":"4","key":"B131","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00281-012-0312-1","article-title":"From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases","volume":"34","author":"Kumar","year":"2012","journal-title":"Semin Immunopathol"},{"issue":"9240","key":"B132","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/S0140-6736(00)02880-4","article-title":"Onset of coeliac disease during treatment with interferon for chronic hepatitis C","volume":"356","author":"Cammarota","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"B133","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1572-0241.2001.03574.x","article-title":"Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease","volume":"96","author":"Adinolfi","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"9258","key":"B134","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0140-6736(05)71230-7","article-title":"Onset of coeliac disease and interferon treatment","volume":"357","author":"Bourliere","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"B135","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/gut.48.3.425","article-title":"Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease","volume":"48","author":"Monteleone","year":"2001","journal-title":"Gut"},{"issue":"2","key":"B136","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1590\/S0004-28032004000200012","article-title":"Celiac disease onset after pegylated interferon and ribavirin treatment of chronic hepatitis C","volume":"41","author":"Martins","year":"2004","journal-title":"Arq Gastroenterol"},{"issue":"6","key":"B137","first-page":"360","article-title":"Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin","volume":"112","author":"Gombosova","year":"2011","journal-title":"Bratisl Lek Listy"},{"issue":"10","key":"B138","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/00004836-200411000-00014","article-title":"Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome","volume":"38","author":"Durante-Mangoni","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/1756-0500-5-533","article-title":"Coeliac disease and C virus-related chronic hepatitis: a non association","volume":"5","author":"Gravina","year":"2012","journal-title":"BMC Res Notes"},{"issue":"8","key":"B140","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1002\/1521-4141(200108)31:82247::AID-IMMU22473.0.CO;2-4","article-title":"Interferon-alpha drives T cell-mediated immunopathology in the intestine","volume":"31","author":"Monteleone","year":"2001","journal-title":"Eur J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00258\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:01:06Z","timestamp":1489449666000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00258\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":140,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00258","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,14]]}}}